Protein Kinase C Inhibitor Sotrastaurin in De Novo Liver Transplant Recipients: A Randomized Phase II Trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-6143|15|5|1283-1292

ISSN： 1600-6135

Source： AMERICAN JOURNAL OF TRANSPLANTATION, Vol.15, Iss.5, 2015-05, pp. : 1283-1292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One‐Year Results of a Scandinavian Randomized Trial

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 7, 2015-07 ,pp. : 1967-1975

John Wiley & Sons Inc

Access to resources Recommend Favorite

Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged‐Release Tacrolimus Regimens—The DIAMOND Study

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 7, 2015-07 ,pp. : 1843-1854

John Wiley & Sons Inc

Access to resources Recommend Favorite

Progression of liver fibrosis in HCV‐positive liver transplant recipients randomized to everolimus with reduced calcineurin inhibitor (CNI) therapy or a standard CNI regimen

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 3, 2015-03 ,pp. : 373-374

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sotrastaurin in Liver Transplantation: Has It Had a Fair Trial?

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 5, 2015-05 ,pp. : 1137-1138

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients – a three‐yr serial echocardiographic substudy of the randomized controlled CENTRAL trial

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 8, 2015-08 ,pp. : 678-684

John Wiley & Sons Inc

Access to resources Recommend Favorite